Awni Alshurafa Mohamed A Yassin
10.3389/fmed.2022.1048571
Front Med (Lausanne)
2022 Nov 29;9:1048571.
crizanlizumab hemolytic anemia infusion-related reactions sickle cell disease vaso-occlusive crisis
CC BY
https://pubmed.ncbi.nlm.nih.gov/36523780/
Case Reports
PMC9745667
36523780
Short- and long-term follow-up and additional benefits in a sickle cell disease patient experienced severe crizanlizumab infusion-related vaso-occlusive crisis: A case report
2022